InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-29.0%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Koppel Adam, 董事. Director active across 4 companies, notably Dicerna Pharmaceuticals Inc. In total, 10 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €139.6m. History available since 3 June 2021. The latest transaction was filed on 20 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Koppel Adam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
16,875,000 股Common StockSEC:0001193125-26-164407:0
4,145,768 股Common StockSEC:0001193125-26-164407:1
1,562,500 股@ US$16.00100.0% 占其流量Common StockSEC:0001193125-26-164407:2
标准退出：2026年7月19日 (T+90)
3,282 股Common StockSEC:0000950170-24-090903:0
10,461 股Common StockSEC:0000950170-24-070855:0
904,160 股@ US$5.53100.0% 占其流量Common StockSEC:0000950170-24-004276:0
5,480,052 股@ US$22.81100.0% 占其流量Common StockSEC:0000899243-23-019971:0
标准退出：2024年1月14日 (T+90)
3,282 股Common StockSEC:0000899243-23-015220:0
3,333 股@ US$38.25100.0% 占其流量Common StockSEC:0000899243-21-050036:0
3,333 股0Common StockSEC:0000899243-21-022369:0
10 条申报中的 10 条
About Koppel Adam
Koppel Adam is a Board Member at Dicerna Pharmaceuticals Inc. He plays an important role in the company's leadership, providing his expertise to guide strategic decisions and foster innovation.
